Andromeda Surgical

Seed / Series A

defense-autonomy · Seed

Seed Signal Score

9/25

Team Strength

2/5

Validation Depth

2/5

Novelty

2/5

Market Timing

1/5

Capital Efficiency

2/5

www.andromedasurgical.com

Description

Autonomous surgical robots

Validation Signals

yc batch

Score Rationale

Andromeda Surgical is categorized as defense-autonomy but appears to be a medical robotics company with no visible defense angle, government contracts, or named founders—YC acceptance alone does not substitute for domain expertise in defense. The autonomous surgical robot space is crowded with well-funded incumbents (Intuitive, CMR Surgical, etc.), and there is no evidence of DoD pull, SBIR awards, or military application, making this a poor fit for defense-tech investment thesis.

Back to all companies